Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus
Top Cited Papers
- 1 June 2016
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 17 (6), e231-e239
- https://doi.org/10.1016/s1470-2045(16)30035-3
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Hospital contact for mental disorders in survivors of childhood cancer and their siblings in Denmark: a population-based cohort studyThe Lancet Oncology, 2013
- Measuring Vincristine-Induced Peripheral Neuropathy in Children With Acute Lymphoblastic LeukemiaCancer Nursing, 2013
- Asparaginase‐associated pancreatitis in childrenBritish Journal of Haematology, 2012
- Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6‐mercaptopurine dosing but not event‐free survival for childhood acute lymphoblastic leukemiaEuropean Journal of Haematology, 2011
- Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemiaLeukemia, 2011
- The frequency and management of asparaginase‐related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana‐Farber Cancer Institute consortium protocolsBritish Journal of Haematology, 2011
- Posterior reversible encephalopathy syndrome in childhood cancerAnnals of Oncology, 2010
- Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemiaPharmacogenetics and Genomics, 2008
- Chronic Health Conditions in Adult Survivors of Childhood CancerThe New England Journal of Medicine, 2006
- SEIZURES IN CHILDHOOD LYMPHOBLASTIC LEUKAEMIA PATIENTSThe Lancet, 1984